Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

MDB-17. THE PTBP2 SPLICING FACTOR IS ESSENTIAL IN GROUP 3/4 MEDULLOBLASTOMA

View through CrossRef
Abstract Medulloblastoma (MB) is a common malignant pediatric brain tumor with significant heterogeneity among its four molecular subgroups WNT, SHH, Group 3 and 4. Group 3/4 MB are aggressive with a relatively poor prognosis indicating a critical need for novel therapeutic targets. Since the transcriptomic profiling of MB subgroups has not resulted in the expected identification of therapeutic potential, we focused on a proteomic approach. Building upon our previously published quantitative proteomic study, we selected 157 proteins significantly over-expressed in Group 3/4 MB. By using targeted loss-of-function CRISPR-Cas9 screen in four MB cell lines, we identified 17 essential genes shared by at least 2 of the cell lines. The PTBP2 splicing factor was essential to the survival of all cell lines. PTBP2 is an RNA binding protein involved in splicing regulation playing an important role during neuronal maturation. We hypothesize that persistent expression of PTBP2 results in a differentiation arrest and preservation of proliferative potential. To evaluate the role of PTBP2 in group 3/4 MB biology, we used single target CRISPR-Cas9 to stably knock-out PTBP2 expression in D556 and MB002 MB cells. We performed bulk RNA-seq and quantitative proteomics of these KO clones along with CLIP-seq to map PTBP2 targeted transcripts. We also performed phenotype assays in KO clones. RNA-seq in PTBP2 KO MB cells revealed 2,213 differentially expressed genes predominantly involved in neuronal differentiation and antigen presentation. These genes were cross-referenced with quantitative proteomics and eCLIP data. Phenotype assays of PTBP2 KO cells revealed reduced proliferation and migration compared to controls. To study the effect of PTBP2 on MB differentiation, we stimulated MB002 PTBP2 KO cells with FBS and observed increased surface attachment and differentiated morphology compared to controls. This suggests that persistent PTBP2 expression inhibits differentiation in MB cells with an attendant increase of proliferation activity.
Title: MDB-17. THE PTBP2 SPLICING FACTOR IS ESSENTIAL IN GROUP 3/4 MEDULLOBLASTOMA
Description:
Abstract Medulloblastoma (MB) is a common malignant pediatric brain tumor with significant heterogeneity among its four molecular subgroups WNT, SHH, Group 3 and 4.
Group 3/4 MB are aggressive with a relatively poor prognosis indicating a critical need for novel therapeutic targets.
Since the transcriptomic profiling of MB subgroups has not resulted in the expected identification of therapeutic potential, we focused on a proteomic approach.
Building upon our previously published quantitative proteomic study, we selected 157 proteins significantly over-expressed in Group 3/4 MB.
By using targeted loss-of-function CRISPR-Cas9 screen in four MB cell lines, we identified 17 essential genes shared by at least 2 of the cell lines.
The PTBP2 splicing factor was essential to the survival of all cell lines.
PTBP2 is an RNA binding protein involved in splicing regulation playing an important role during neuronal maturation.
We hypothesize that persistent expression of PTBP2 results in a differentiation arrest and preservation of proliferative potential.
To evaluate the role of PTBP2 in group 3/4 MB biology, we used single target CRISPR-Cas9 to stably knock-out PTBP2 expression in D556 and MB002 MB cells.
We performed bulk RNA-seq and quantitative proteomics of these KO clones along with CLIP-seq to map PTBP2 targeted transcripts.
We also performed phenotype assays in KO clones.
RNA-seq in PTBP2 KO MB cells revealed 2,213 differentially expressed genes predominantly involved in neuronal differentiation and antigen presentation.
These genes were cross-referenced with quantitative proteomics and eCLIP data.
Phenotype assays of PTBP2 KO cells revealed reduced proliferation and migration compared to controls.
To study the effect of PTBP2 on MB differentiation, we stimulated MB002 PTBP2 KO cells with FBS and observed increased surface attachment and differentiated morphology compared to controls.
This suggests that persistent PTBP2 expression inhibits differentiation in MB cells with an attendant increase of proliferation activity.

Related Results

Polypyrimidine Tract-binding Protein 2 is a Potential Treated Target in Tg(SOD1*G93A)1Gur Mice
Polypyrimidine Tract-binding Protein 2 is a Potential Treated Target in Tg(SOD1*G93A)1Gur Mice
Abstract The function of polypyrimidine tract-binding protein 2 (PTBP2) is the regulator of neuronal fate during central nervous system development. The possible relationsh...
Abstract 6505: Targeting PINK1 reduces medulloblastoma progression in animal models
Abstract 6505: Targeting PINK1 reduces medulloblastoma progression in animal models
Abstract Medulloblastoma is a brain cancer that mainly arises during infancy and childhood. Medulloblastoma is the most common pediatric malignant brain tumor worldw...
ANALISIS PERTIMBANGAN MAHKAMAH AGUNG DALAM MENGABULKAN KASASI TERDAKWA (STUDI PUTUSAN NOMOR 2959/K/PID.SUS/2022)
ANALISIS PERTIMBANGAN MAHKAMAH AGUNG DALAM MENGABULKAN KASASI TERDAKWA (STUDI PUTUSAN NOMOR 2959/K/PID.SUS/2022)
<p><em><span class="markedContent"><span style="left: calc(var(--scale-factor)*195.53px); top: calc(var(--scale-factor)*496.87px); font-size: calc(var(--scale-...
Genome-wide survey of allele-specific splicing in humans
Genome-wide survey of allele-specific splicing in humans
Abstract Background Accurate mRNA splicing depends on multiple regulatory signals encoded in the transcribed RNA sequence. Many examples of mutat...
Abstract 1872: Targeting MYC-driven medulloblastoma using inhibitors of glutamine metabolism.
Abstract 1872: Targeting MYC-driven medulloblastoma using inhibitors of glutamine metabolism.
Abstract Medulloblastoma is the most common malignant brain tumor in children. Currently, treatment consists of surgical resection, chemotherapy, and whole brain and...
Abstract 778: Dysregulation of alternative mRNA splicing by oncogenic KRAS in lung adenocarcinoma
Abstract 778: Dysregulation of alternative mRNA splicing by oncogenic KRAS in lung adenocarcinoma
Abstract Alternative mRNA splicing is dysregulated in many cancers including lung adenocarcinoma. These aberrant splicing events can sometimes be explained by mutati...

Back to Top